Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01IRW
|
||||
| Former ID |
DIB011066
|
||||
| Drug Name |
Bermoprofen
|
||||
| Synonyms |
Dibenon; Bermoprofen potasium salt; AD-1590; AJ-1590
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Discontinued in Preregistration | [1] | ||
| Company |
Dainippon Pharmaceutical Co Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H16O4
|
||||
| Canonical SMILES |
c12C(=O)Cc3c(Oc1ccc(c2)C(C(=O)O)C)ccc(c3)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000932) | ||||
| REF 2 | Prolongation of antipyretic action and reduction of gastric ulcerogenicity in the rat by controlled-release granules of bermoprofen, a new nonsteroidal anti-inflammatory drug. J Pharm Sci. 1991 Sep;80(9):876-80. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.